Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogenic myelin-reactive CD4+ T helper cells are a subset of immune cells that recognize and respond to components of myelin, the insulating sheath around nerve fibers in the central nervous system (CNS). These autoreactive T cells play a central role in the development and progression of autoimmune demyelinating diseases such as multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). They become activated when they encounter myelin-derived antigens presented by antigen-presenting cells (APCs) via MHC class II molecules. Upon activation, they differentiate into various effector subsets—primarily Th1 and Th17—which secrete proinflammatory cytokines such as IFN-γ, IL-17, GM-CSF, and others. The inflammatory milieu created by these cytokines leads to recruitment of additional immune cells into the CNS, resulting in inflammation, demyelination, oligodendrocyte injury, and neurodegeneration.
Targeting these pathogenic populations or their effector functions is a major focus for immunomodulatory therapies in MS. Strategies include blocking key cytokines like IL‑17 or GM‑CSF or modulating costimulatory pathways involved in their activation/differentiation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic Myelin-Reactive CD4+ T Helper Cell (None).